miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2058-7716
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation ; volume:8 ; number:1 ; day:27 ; month:6 ; year:2022 ; pages:1-11 ; date:12.2022
Cell death discovery ; 8, Heft 1 (27.6.2022), 1-11, 12.2022
- Creator
-
Li, Li
Yu, Shijun
Chen, Jingde
Quan, Ming
Gao, Yong
Li, Yandong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41420-022-01094-2
- URN
-
urn:nbn:de:101:1-2022081921082177259139
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Li
- Yu, Shijun
- Chen, Jingde
- Quan, Ming
- Gao, Yong
- Li, Yandong
- SpringerLink (Online service)
Other Objects (12)
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
MiR
miR
Increased miR-20b Level in High Grade Cervical Intraepithelial Neoplasia
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
miR-9 upregulation leads to inhibition of erythropoiesis by repressing FoxO3
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
MiR
miR
Increased miR-20b Level in High Grade Cervical Intraepithelial Neoplasia
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
miR-9 upregulation leads to inhibition of erythropoiesis by repressing FoxO3
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
MiR
miR
Increased miR-20b Level in High Grade Cervical Intraepithelial Neoplasia
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
miR-9 upregulation leads to inhibition of erythropoiesis by repressing FoxO3
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR